Cisco Systems Inc vs McKesson Corporation — how do they compare? Cisco Systems Inc trades at $122.45 (market cap $474.67B), while McKesson Corporation trades at $899.7 (market cap $105.14B). The key difference: Cisco Systems Inc is far larger — about 4.5× McKesson Corporation's market cap, and Cisco Systems Inc pays the higher dividend (1.4%). Which is the better fit depends on your goals.
| CSCO | MCK | |
|---|---|---|
Market Cap | $474.67B | $105.14B |
Volume | 22,887,319 | — |
Sector | Technology | Health |
52-Week High | $130.00 | $995.69 |
52-Week Low | $66.20 | $659.01 |
Enterprise Value | $489.33B | $111.67B |
Dividend Yield | 1.4% | 0.42% |
Signals from Pluang's Aura AI — not financial advice
Cisco Systems (CSCO) trades at $120.43, down 0.82% on the day, amid a bullish technical outlook and strong earnings beats. The stock shows robust fundamentals with a 64.33% gross margin and consistent quarterly EPS outperformance. Recent AI cybersecurity initiatives and partner expansions fuel positive sentiment, with a consensus price target of $133.25 implying upside potential.
The outlook remains favorable given AI-driven growth catalysts and solid cash flow, though elevated valuation ratios and competitive pressures pose risks. Analyst consensus leans bullish with 52% buy ratings, supporting a constructive view for investors seeking exposure to networking and cybersecurity trends.
No Aura AI signal available yet.
Trailing returns across standard periods
Latest headlines on both assets
Cisco Systems, Inc. provides information technology and networking services. The Company offers enterprise network security, software development, data collaboration, cloud computing, and other related services. Cisco Systems serves customers in the United States.
Read more on CSCO →McKesson is a leading wholesaler of branded, generic, and specialty pharmaceutical products to pharmacies (retail chains, independent, and mail order), hospitals networks, and healthcare providers. Along with AmerisourceBergen and Cardinal Health, the three account for well over 90% of the U.S. pharmaceutical wholesale industry. McKesson is currently divesting from its pharmaceutical wholesale and distribution in Europe and Canada in order to redeploy capital to strategic growth areas in the U.S. (oncology network and ecosystem, and biopharma services). Additionally, the company supplies medical-surgical products and equipment to healthcare facilities and provides a variety of technology solutions for pharmacies.
Read more on MCK →